New shot in the eye aims to slow blinding disease
NCT ID NCT07160179
Summary
This study is testing a new eye injection called ABBV-6628 for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes vision loss. The main goals are to check the safety of the injection and see how the body processes it. Researchers will also gather early information on whether it can slow the progression of the disease compared to an existing treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Consultants - The Woodlands /ID# 262138
RECRUITINGThe Woodlands, Texas, 77384, United States
-
Retina Foundation of the Southwest /ID# 262479
RECRUITINGDallas, Texas, 75231, United States
Contact Phone: •••-•••-••••
-
Retina Partners Midwest, P.C. /ID# 262172
RECRUITINGCarmel, Indiana, 46032, United States
-
Retina Research Institute of Texas /ID# 262141
RECRUITINGAbilene, Texas, 79606-1224, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.